The folylpolyglutamate synthetase-dihydrofolate synthetase gene (foiC) 
methionine and stimulated by glycine in the absence of vitamin B12. This mutant is leaky so that the cells have dihydrofolate synthetase and FPGS activity at levels 1 to 3% of the levels of the wild-type strain and possess 10 to 30% of normal total folate pools (11) . Because the dihydrofolate synthetase activity is required for folate biosynthesis, a nonleaky mutant having no residual enzyme activity would have no folates. Such a mutant would require all of the folate end products (thymine, purines, glycine, methionine, and pantothenate), or it may be lethal, since folate is also required for synthesis of formyl methionine for initiation of protein synthesis. We wished to obtain afolC mutant which completely lacks FPGS-dihydrofolate synthetase activity to investigate its phenotype.
A number of methods for gene disruption and allele replacement in E. coli have been reported previously (3, 14, 15, 33) . Double-stranded linear DNA fragments containing the folC gene with a Kmr cassette inserted into the coding sequence failed to transform a recBC sbcB strain to kanamycin resistance. In our hands these methods did not work even in the presence of a complementing wild-type plasmid.
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The recent report of the deletion of the folA gene encoding dihydrofolate reductase in a poLA thyA strain by integration of recombinant plasmids containing the ColEl origin and their subsequent segregation (14) suggested to us that constructing a deletion of foiC by a similar method may be successful.
The SF4 mutant strain contains a folC gene with a point mutation causing an alani, e-to-threonine amino acid change at codon 309 (16) and re,,dires methionine for growth (11) .
Plasmid-encoded mutant foiC genes which express as little as 1% of the wild-type activity of either FPGS or dihydrofolate synthetase complemented SF4 to methionine prototrophy (16, 17) . The Lactobacillus casei FPGS gene, which has little or no dihydrofolate synthetase activity, can also complement SF4 (31) . We have constructed a number of folC mutants on multicopy plasmids by in vitro mutagenesis, but the study of their properties was hampered by the background enzyme activity of the SF4 strain. In this report, we demonstrate the deletion of the chromosomal folC gene in the presence of a complementing gene on a plasmid temperature sensitive for replication. The complementing plasmid can then be replaced by a second plasmid containing a foiC mutant gene, provided that the gene product expresses sufficient enzyme activity. This allows the' study of many folC mutants synthesized in vitro in the absence of background FPGS-dihydrofolate synthetase activity encoded by the chromosome.
MATERIALS AND METHODS
Materials. [a-32P]dATP (7, 000 Ci/mmol), [ (5). Incorporation of labelled para-aminobenzoic acid into cellular folates. 2YT medium was pretreated with activated charcoal and filtered to remove any folates or para-aminobenzoic acid. para-Amino[carboxyl-'4C]benzoic acid (54 mCi/mmol) was added to 20 ml of the medium (12,000 cpm/ml) at a concentration of 0.2 FtM. The medium was inoculated with the appropriate E. coli strains and shaken for 24 h. The cells were washed twice by centrifugation and counted by using Aquasol scintillation fluid.
Analysis of plasmid-encoded gene products in maxicells. E.
coli DR1984 was transformed with various plasmids and irradiated with UV light, and plasmid-encoded proteins were labelled with Tran3 S-label (methionine and cysteine) as described by Sancar et al. (26) . Sodium dodecyl sulfatepolyacrylamide gel electrophoresis was performed with 13% polyacrylamide gels according to the method of Laemmli (18) , and the gels were fluorographed.
RESULTS
Construction of plasmid pCP3. The construction of pCP3 is shown in Fig. 1 . All plasmid constructs were verified by restriction enzyme analysis, including redigestion of pCP3 with StuI (data not shown).
The gene products expressed from pCP3 were analyzed in maxicells (Fig. 2, lane 3) . The pCP3 plasmid expressed the labelled protein products expressed by its parent plasmid H2al (lane 4) but did not express the products of the foiC gene, the dedD gene, or the TnS Kmr gene (kan 2 in Fig. 2 ), since these genes were deleted in the construction of pCP3.
ThefolC product (molecular mass, 47 kDa) is shown in lanes 2, 4, and 5. The dedD product (35 kDa) is shown in lane 4 and is present as a very faint band in lane 2. The product of the Kmr gene from pUC4K (lane 1) appears to have the same mobility as the ,-lactamase and is not visible as a discrete band.
Integration of pCP3 and deletion of chromosomal sequences. Our strategy for disruption of the chromosomal folC gene is shown in Fig. 3A . pCP3 contains a selectable Kmr marker replacing the deletedfolC and dedD genes, and the marker is flanked by extensive E. coli genomic DNA sequences required for homologous recombination. pCP3 was used to transform the polA(Ts) strain MM383 to ampicillin and kanamycin resistance. We tried several times but were unable to isolate any plasmid from transformants in MM383, suggesting that all had the plasmids directly integrated into the chromosome. Integration of intact pCP3 into the chromosomes of Ampr Kmr transformants was verified by Southern blot analysis (Fig. 3B) . The pCP3 probe hybridized to a 9-kb and a 2.7-kb EcoRI fragment in the host strain (lanes 1 and 2). The recombination event could occur on either side of the deletion (Fig. 3A) , and both possible integrants were obtained. Fig. 3B, (Fig. 3A, bottom left) .
Replacement of thefoiC gene with in vitro-generated mutant genes. One of our objectives in deleting thefolC gene was to express mutantfolC genes produced by in vitro mutagenesis in a strain with no chromosomally encoded background enzyme activity. Since all of our mutants were constructed in ColEl replicons, it was necessary to transduce the chromosomal foiC deletion into a PolA+ strain by using bacteriophage P1 as described in Materials and Methods. We selected for Kmr in transductants of strain SF2 containing the pPMpac3a plasmid. We obtained no Kmr transductants if the recipient strain did not contain a complementing pPMpac3a plasmid. The loss of the chromosomal foiC gene in these strains was verified by Southern blot analysis. For the blot shown in Fig. 3C the BamHI-HindIII fragment of the plasmid pACS (Fig. 5) (23) . The deletion also removed the last 5 bases, including the termination codon of the usg. A Km' cassette which was inserted into pCP2 was constructed as follows: plasmid pUC4K (Pharmacia) was digested with BamHI, and the 1.3-kb DNA fragment containing the kanamycin phosphotransferase gene was isolated from an agarose gel and ligated into the BglII site of pUGBgl (6) . pUGBgl has a linker consisting of the BglII site flanked by StuI sites, which contains DNA sequences to provide the proper termination for the upstream gene while allowing insertions into the BglII site (6) . The ized only to the 4.5-kb EcoRI and the 2.7-kb EcoRI-Smal fragments corresponding to the pPMpac3a-encoded folC gene but not to the 9-kb chromosomal EcoRI fragment from the parental strain, SF2 (shown in lane 3). There are no SmaI sites within this chromosomal EcoRI fragment (23) .
SF2AfolC/pPMpac3a was transformed to ampicillin resistance with plasmids pUC19 and pAC5 (wild-type folC gene in pUC19) or plasmids containing mutatedfolC genes in pUC vectors (Table 1) . pL2, pIA, pL5, pL6, pL8, and pLlO were derived from pAC5 and contain 2-amino-acid linker insertions at various points in the foiC coding sequence (17) . Plasmids pSF4, pGly, pIleu, pVal, pArg, pGlu, and pLeu contain point mutations in codon 309 offoiC (the site of the mutation in SF4), and the DNA inserts also contain the entire dedD gene (16) . Plasmid pGT3-8.1 contains the L. casei FPGS gene (30) . All of the mutant plasmids tested, except pArg, pLeu, and pGlu, transformed strain SF4 to methionine prototrophy. The SF2AfolC/pPMpac3a Ampr transformants were grown at 37°C in the absence of tetracycline and then replica plated onto tetracycline-supplemented medium to screen for segregation of the pPMpac3a plasmid.
Most of the colonies from pAC5-transformed cells were tetracycline sensitive, indicating that the pPMpac3a plasmid had segregated, but none of the pUC19-transformed cells were tetracycline sensitive. The pPMpac3a plasmid segregated from transformants containing the codon 309 point mutants when these were plated on complex medium. The SF2AfolC strains containing pVal, pArg, pLeu, and pGlu grew more slowly than the wild type. SF2AfolC strains transformed with the linker insertion mutants (all of which had <5% of wild-type FPGS or dihydrofolate synthetase activity) (17) were unable to segregate the pPMpac3a plasmid even when grown on complex medium.
In one experiment, the pPMpac3a plasmid segregated from SF2AfolC/pGT3-8.1, (containing the L. casei FPGS gene). SF2AfolC/pGT3-8.1 grew only on complex medium and could be stably maintained, but we have not been able to repeat the transformation and segregation experiment that produced this strain. The loss of both the chromosomal and pPMpac3a-encoded folC genes from the Tets strains from which pPMpac3a had segregated was verified by Southern blotting. Figure 3B , lanes 4 to 6, shows that thefolC-specific probe hybridized only to 4-to 4.7-kb DNA fragments specific for the replacing plasmids and not to the 2.6-kb pPMpac3a plasmid-specific fragment (lane 2) or any chromosomal integrant. Lane 4 contained the same amount of DNA as lanes 5 and 6 did, but the L. casei FPGS gene-specific DNA hybridized only weakly to the folC probe. To verify that SF2AfolC/pGT3-8.1 contained only the L. casei FPGS gene, extracts of the strain and controls were assayed for FPGS and dihydrofolate synthetase activity. Table 2 shows that SF2AfolC/pGT8-1 has very high expression of FPGS activity,withsixfold-higheractivitywith5,10-methylenetetrahydrofolate than with 10-formyl tetrahydrofolate, similar to the specificity of the enzyme purified from L. casei. The dihydrofolate synthetase specific activity is less than that of the wild-type E. coli, indicating that the chromosomal and pPMpac3a foiC genes are absent. The apparent dihydrofolate synthetase activity of the L. casei FPGS may be due in part to traces of folate in the pteroate substrate. Table 3 shows incorporation of 14C-para-aminobenzoic acid into the cells, which is another measure of folate biosynthesis and dihydrofolate synthetase activity. complement the folC function, as it is in FPGS-deficient Chinese hamster ovary cells (29) . The folate requirement for synthesis of formyl-methionyl-tRNA for the initiation of protein synthesis would not be satisfied by these supplements (11) . Since the biosynthesis of folate requires dihydrofolate synthetase, the dihydrofolate synthetase activity of the folC gene product may be essential. We have not obtained any folC mutants which have dihydrofolate synthetase activity but no FPGS activity, so we could not determine whether dihydrofolate synthetase activity alone is sufficient for cell viability. The loss of FPGS alone may simply result in methionine auxotrophy (11) . A major application of the strains we have constructed is as recipient strains for mutant foiC genes, synthesized in vitro, which allow examination of the mutants in the absence of a background activity from the chromosomal gene. We have constructed such strains as well as a strain in which the FPGS gene of L. casei replaced the folC gene. We will now be able to purify the mutant enzymes and study their properties. The mutant genes were all present in high copy number, and the enzymes were expressed as about 4% of soluble cellular protein, but in the strains complemented by the pGlu, pArg, and pLeu mutant genes, the enzyme-specific activity in the cells was much lower than that in the wild type (16) . The lower the specific activity of the enzyme was, the more supplements of folate end products were required for growth. The decrease in enzyme activity in the IB1 (SF2 and SF4) strain resulted in a 70% decrease in intracellular folate pools (11) . The level of enzyme activity was even lower in the SF2AfolC/pArg, SF2AfolC/pLeu, and SF2AfolC/pGlu strains than in SF2, suggesting that folate pools may be lower in these strains, resulting in the lower growth rates and auxotrophies. The methionine biosynthetic pathway appears to be most sensitive to low folate, followed by glycine biosynthesis, while biosynthesis of nucleotides and pantothenate are the least sensitive. Studies to measure the levels of folate in the strains described here are in progress and will allow us to determine the folate concentrations which limit the growth of the cell and the functioning of each folatedependent biosynthetic pathway.
The strain containing the L. casei gene, SF2AfolC/pGT3-8.1, expresses levels of FPGS activity that are 1.8-fold higher than those in SF2AJolC/pAC5 with the E. coli foiC gene in the same vector. However, SF2AfolCIpGT3-8.1 is auxotrophic for all of the folate end products. This auxotrophy is probably due to extremely low levels of dihydrofolate synthetase activity in the L. casei enzyme. The incorporation ofpara-aminobenzoic acid, a measure of folate synthesis, was 0.2% that of the wild type in SF2AfolC/pGT3-8.1.
The dihydrofolate synthetase-specific activity of the L. casei enzyme ( Table 2 ) was 1/10,000 that of the E. coli enzyme, but with the high expression of the L. casei gene, the total enzyme activity would be sufficient to account for the viability of SF2AfolC/pGT3-8.1. Preliminary results from extraction and high-performance liquid chromatography of cellular folates suggest that SF2AfolC/pGT3-8.1 does contain folates (30) , favoring this interpretation. The L. casei gene in the strain may have undergone a mutation to give it some dihydrofolate synthetase activity, because we have not been able to repeat the experiment in which we constructed this strain. An alternate possibility is that the E. coli genome in the recipient SF2AfolC that was transformed with pGT3-8.1 had undergone a second mutation, making it able to initiate protein synthesis without formyl methionine. Such a mutant has been reported in the literature (1), although it has been subsequently lost.
